Adaptive Biotechnologies Corporation (FRA:1HM)
Germany · Delayed Price · Currency is EUR 15.11
-0.15 (-0.95%)
Jan 16, 2026, 4:00 PM EST
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of €2.38 billion as of January 30, 2026. Its market cap has increased by 131.48% in one year.
Market Cap
2.38B
Enterprise Value
2.37B
Revenue
215.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€15.11
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from 4.20B to 2.38B, a decrease of -43.41%. That is a compound annual growth rate of -8.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.38B | 12.58% |
| Dec 31, 2025 | 2.11B | 147.10% |
| Dec 31, 2024 | 854.57M | 33.16% |
| Dec 29, 2023 | 641.78M | -37.23% |
| Dec 30, 2022 | 1.02B | -70.64% |
| Dec 31, 2021 | 3.48B | -47.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |